Advanced Search


Study ID Status Title Patient Level Data
114937 Completed Burden of Frequent and Infrequent Exacerbating Patients with Chronic Obstructive Pulmonary Disease (COPD)
114940 Active, Not Recruiting USHO-11-3281: Predictors of stepping down asthma therapy: observational study and Fluticasone propionate-Salmeterol Combination Therapy outcomes study
114941 Active, Not Recruiting Assessment of asthma-related resources after initiation of an inhaled corticosteroid switch: Observational study
114951 Completed DB2114951: A randomized, multi-center, double-blind, double-dummy, parallel group study to evaluate the efficacy umeclidinium/vilanterol compared with fluticasone propionate/salmeterol over 12 weeks in subjects with COPD Study Listed on
114955 Completed Retrospective Administrative Claims Database Evaluation of Utilization of Belimumab in United States Managed Care Settings
114956 Completed A 4-Week Randomized Cross-Over Study to Evaluate Daily Lung Function Following the Administration of Albuterol/Salbutamol and Ipratropium in Subjects with Chronic Obstructive Pulmonary Disease Study Listed on
114957 Completed A Randomized, Open-label, Single-dose, Two-period, Crossover Study to Demonstrate the Bioequivalence of the Fixed Dose Combination (FDC) of lamivudine and adefovir dipivoxil (100mg/10mg) to Heptodin® (100mg ) and Hepsera® (10mg) Study Listed on
114974 Completed A randomised, double blind placebo controlled, 2 way cross over study in adults with non-allergic rhinits to evaluate the effect of once daily administration of intranasal SB-705498 12mg for two weeks and the response to a chamber challenge of cold dry air Study Listed on
114985 Completed A first time in human, single blind, randomized, placebo-controlled,dose escalating crossover study to evaluate the safety,tolerability, pharmacokinetic and pharmacodynamic parameters of single doses of GSK2330672 in healthy volunteers Study Listed on
114987 Terminated An open-label, phase 2a study to evaluate pazopanib eye drops administered for 12 weeks to patients with neovascular age-related macular degeneration
114989 Completed Neisseria meningitidis burden of disease
114991 Completed Neisseria meningitidis carriage study
114993 Completed SUrvey of Guideline Adherence for treatment of systolic heart failure in Real WorldMulticenter, retrospective observation study in Korea
114995 Completed A Phase I, Randomized, Placebo-Controlled, Parallel-Group, Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Dose of the Captisol™ Formulation of Vestipitant (GW597599) in Healthy Adult Subjects
115002 Active, Not Recruiting PGx308, PGx309, PGx310 and PGx382 evaluation of efficacy and safety endpoints in pazopanib-treated renal cell carcinoma (RCC) patients in studies VEG102616, VEG105192, and VEG107769
115003 Completed PGx367 evaluation of ALT elevation in patients receiving pazopanib and statins in 11 pazopanib clinical studies (VEG102616, VEG105192, VEG107769, VEG10003, VEG10004, VEG10005, VEG10007, VEG20002, VEG20006, VEG104450, VEG105281)
115-003 Completed A Multicentre Pilot Study in the United Kingdom to Determine Whether 566C80 Exhibits Antimalarial Activity in Patients with P. Falciparum Malaria.
115005 Completed PGx368 Genetics asthma exacerbation in ADA109055, ADA109057, SFA103153, I13106870
115-005 Completed An Open Study to Determine Whether 566C80 (Atovaquone) Exhibits Antimalarial Activity in Thai Patients with P. falciparum Malaria
115008 Completed Medical Record Review and Data Abstraction for Pediatric, Adolescent and Pregnant Patients treated with IV zanamivir in the Relenza Compassionate Use Program Study Listed on
115-012 Completed An open study to determine whether 566C80 (atovaquone) exhibits antimalarial activity in Zambian patients with P. falciparum malaria
115014 Completed SLE in CEE setting( Hungary, Poland, Romania) an insight on medical, economic and social burden
115030 Completed Efficacy and Safety of Belimumab in a Subgroup of Systemic Lupus Erythematosus (SLE) Patients with Higher Disease Activity (anti-dsDNA positive and low complement): A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies
115032 Completed A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on
115040 Terminated A Randomized, Double Blind, Dose Escalation, Fusion, First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.